The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu. The company said it was notified Wednesday that the Health and Human Services Department had withdrawn funds awarded in July 2024 and in January to pay for development and … Read more
In May 2025, the U.S. Government Accountability Office (GAO) released a Science & Tech Spotlight report titled Universal Vaccines (GAO-25-108286), examining a promising new frontier in immunization strategy. The report outlines how universal vaccines—designed to protect against a wide range of virus strains—could “provide long-lasting, broad protection against specific viruses and reduce the impact of … Read more
The Quest for Lasting Immunity: Exploring the Potential of Universal Vaccines Table of Contents The Quest for Lasting Immunity: Exploring the Potential of Universal Vaccines Beyond Reactive Immunization: A Paradigm Shift in Vaccine Strategy Promising Research, Persistent Delays the Investment Gap: Balancing Public Health with Profitability Broad Protection & Economic Reality: Navigating Your Insurance Options … Read more
Munday JS, Knight CG. Papillomaviruses and papillomaviral disease in dogs and cats: A comprehensive review. Pathogens. 2024;13(12). Medeiros-Fonseca B, Faustino-Rocha AI, Medeiros R, Oliveira PA. Gil Da Costa RM. Canine and feline papillomaviruses: an update. Front Vet Sci. 2023;10:1174673. PubMed PubMed Central Google Scholar Gil da Costa RM, Peleteiro MC, Pires MA, DiMaio D. An … Read more
During one of the most active flu seasons in recent memory, infectious disease experts at Fred Hutch Cancer Center say many of the public health lessons learned during the COVID-19 epidemic still apply: wear well-fitting masks in crowded indoor poorly ventilated spaces, practice good hand hygiene and get vaccinated. There are three vaccines available to … Read more
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) — The “Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global vaccine adjuvants market is projected to surpass USD 960 million in 2029 from USD 700 million in 2024, with a significant CAGR of … Read more